1. Home
  2. ESPR vs ORN Comparison

ESPR vs ORN Comparison

Compare ESPR & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • ORN
  • Stock Information
  • Founded
  • ESPR 2008
  • ORN 1994
  • Country
  • ESPR United States
  • ORN United States
  • Employees
  • ESPR N/A
  • ORN N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • ORN Military/Government/Technical
  • Sector
  • ESPR Health Care
  • ORN Industrials
  • Exchange
  • ESPR Nasdaq
  • ORN Nasdaq
  • Market Cap
  • ESPR 305.0M
  • ORN 316.7M
  • IPO Year
  • ESPR 2013
  • ORN 2007
  • Fundamental
  • Price
  • ESPR $1.54
  • ORN $5.59
  • Analyst Decision
  • ESPR Buy
  • ORN Strong Buy
  • Analyst Count
  • ESPR 7
  • ORN 3
  • Target Price
  • ESPR $6.36
  • ORN $12.50
  • AVG Volume (30 Days)
  • ESPR 4.0M
  • ORN 489.4K
  • Earning Date
  • ESPR 03-04-2025
  • ORN 03-04-2025
  • Dividend Yield
  • ESPR N/A
  • ORN N/A
  • EPS Growth
  • ESPR N/A
  • ORN N/A
  • EPS
  • ESPR N/A
  • ORN N/A
  • Revenue
  • ESPR $332,314,000.00
  • ORN $796,394,000.00
  • Revenue This Year
  • ESPR $5.51
  • ORN $7.86
  • Revenue Next Year
  • ESPR $1.42
  • ORN $11.33
  • P/E Ratio
  • ESPR N/A
  • ORN N/A
  • Revenue Growth
  • ESPR 185.66
  • ORN 11.89
  • 52 Week Low
  • ESPR $1.47
  • ORN $4.85
  • 52 Week High
  • ESPR $3.94
  • ORN $12.12
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 34.95
  • ORN 35.44
  • Support Level
  • ESPR $1.47
  • ORN $5.20
  • Resistance Level
  • ESPR $1.61
  • ORN $5.58
  • Average True Range (ATR)
  • ESPR 0.13
  • ORN 0.46
  • MACD
  • ESPR -0.01
  • ORN -0.08
  • Stochastic Oscillator
  • ESPR 7.69
  • ORN 27.89

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas.

Share on Social Networks: